121 related articles for article (PubMed ID: 1602281)
1. Multiple myeloma--a curable disease?
Gahrton G
J Intern Med; 1992 May; 231(5):449-52. PubMed ID: 1602281
[No Abstract] [Full Text] [Related]
2. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
[TBL] [Abstract][Full Text] [Related]
3. An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
Dinota A; Barbieri L; Gobbi M; Tazzari PL; Rizzi S; Bontadini A; Bolognesi A; Tura S; Stirpe F
Br J Cancer; 1989 Sep; 60(3):315-9. PubMed ID: 2789938
[TBL] [Abstract][Full Text] [Related]
4. Intensive therapy for high grade multiple myeloma (MM).
Harousseau JL; Milpied N; Jouet JP; Colombat P; Guilhot F; Laporte JP; Ifrah N; Gandhour C; Casassus P
Bone Marrow Transplant; 1991; 7 Suppl 2():28. PubMed ID: 1878703
[No Abstract] [Full Text] [Related]
5. Multiple myeloma: current treatment.
Samson D
Postgrad Med J; 1994 Jun; 70(824):404-10. PubMed ID: 7518081
[No Abstract] [Full Text] [Related]
6. Intensive therapy for myeloma.
McElwain TJ; Meldrum M; Gore ME; Millar BC; Malpas JS
Pathol Biol (Paris); 1990 Oct; 38(8):830. PubMed ID: 2274375
[No Abstract] [Full Text] [Related]
7. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.
Cunningham D; Paz-Ares L; Milan S; Powles R; Nicolson M; Hickish T; Selby P; Treleavan J; Viner C; Malpas J
J Clin Oncol; 1994 Apr; 12(4):759-63. PubMed ID: 8151319
[TBL] [Abstract][Full Text] [Related]
8. The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies.
Selby P; Zulian G; Forgeson G; Nandi A; Milan S; Meldrum M; Viner C; Osborne R; Malpas JS; McElwain TJ
Hematol Oncol; 1988; 6(2):173-9. PubMed ID: 3292375
[No Abstract] [Full Text] [Related]
9. Amyloid myopathy and myeloma: response to treatment.
Sheehan-Dare RA; Simmons AV
Postgrad Med J; 1987 Feb; 63(736):141-2. PubMed ID: 3671242
[TBL] [Abstract][Full Text] [Related]
10. Three courses of high dose therapy. Feasibility in the treatment of multiple myeloma--a "France autogreffe" study.
Colombat P; Milpied N; Laporte JP; Casassus P; Linassier C; Harousseu JL
Cancer; 1994 Dec; 74(11):2930-4. PubMed ID: 7954256
[TBL] [Abstract][Full Text] [Related]
11. Melphalan plus prednisolone in the treatment of multiple myeloma.
Begum M; Akther A; Khan KH; Kaiser MS; Rahman MJ; Alam MN
Mymensingh Med J; 2012 Jan; 21(1):93-7. PubMed ID: 22314461
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.
Kanamaru R; Wakui A; Ishioka C; Okuno M; Konishi Y; Ishikawa A; Shibata H
Sci Rep Res Inst Tohoku Univ Med; 1988 Dec; 35(1-4):35-40. PubMed ID: 3267125
[No Abstract] [Full Text] [Related]
13. Intensive treatment of multiple myeloma and criteria for complete remission.
Gore ME; Selby PJ; Viner C; Clark PI; Meldrum M; Millar B; Bell J; Maitland JA; Milan S; Judson IR
Lancet; 1989 Oct; 2(8668):879-82. PubMed ID: 2571812
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of multiple myeloma. Results of sequential treatment with melphalan-prednisolone and the M2 protocol].
Steinke B; Busch FW; Stapelfeld S; Ostendorf P; Waller HD
Dtsch Med Wochenschr; 1984 Jun; 109(26):1015-9. PubMed ID: 6547386
[TBL] [Abstract][Full Text] [Related]
15. Identical twin marrow transplantation in multiple myeloma.
Osserman EF; DiRe LB; DiRe J; Sherman WH; Hersman JA; Storb R
Acta Haematol; 1982; 68(3):215-23. PubMed ID: 6215815
[TBL] [Abstract][Full Text] [Related]
16. The treatment of multiple myeloma.
Alexanian R; Dimopoulos M
N Engl J Med; 1994 Feb; 330(7):484-9. PubMed ID: 8289856
[No Abstract] [Full Text] [Related]
17. Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma.
Wiesmann A; Einsele H; Kanz L; Dohmen BM
Bone Marrow Transplant; 2005 Jul; 36(1):89-90. PubMed ID: 15895113
[No Abstract] [Full Text] [Related]
18. Intermittent melphalan and prednisolone therapy in plasma cell myeloma.
Mellstedt H; Björkholm M; Holm G
Acta Med Scand; 1977; 202(1-2):5-9. PubMed ID: 899883
[TBL] [Abstract][Full Text] [Related]
19. Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.
Cabrera R; Díaz-Espada F; Barrios Y; Briz M; Forés R; Barbolla L; Sanjuán I; Regidor C; Peñalver FJ; Fernández MN
Bone Marrow Transplant; 2000 May; 25(10):1105-8. PubMed ID: 10828874
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation in multiple myeloma.
Gallamini A; Buffa F; Bacigalupo A; Van Lint MT; Peralvo J; Pittaluga PA; Occhini D; Marmont AM
Acta Haematol; 1987; 77(2):111-4. PubMed ID: 3111140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
